Takeda Collaborates with Accenture and AWS to Transform into a Cloud-Based Company

 Takeda Collaborates with Accenture and AWS to Transform into a Cloud-Based Company

Takeda Collaborates with Accenture and AWS to Transform into a Cloud-Based Company

Shots:

  • Takeda has entered into a five-year agreement with Accenture and Amazon Web Services (AWS) to support the company in moving 80% of its applications to the cloud and modernizing its research tools
  • The transition of Takeda’s applications to the cloud will enable the company to remove non-differentiating technology and create a scalable architecture. The collaboration will leverage cloud and data-driven insights to accelerate drug development, increase operational agility, reduce technology costs, and develop the workforce of the future
  • Additionally, the collaboration with Accenture and AWS has already helped the Takeda to use the cloud in launching a clinical trial acceleration and secure data-sharing platform for the COVID R&D Alliance in <5days. The COVID R&D Alliance is a consortium comprising 20 companies, including Takeda, Amgen, and AbbVie to study and identify the potential of COVID-19 therapies

    Click here to­ read the full press release/ article | Ref: Takeda | Image: Enterprise Talk

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post